Skip to main navigation Skip to search Skip to main content

Higher-order interactions of Bcr-Abl can broaden chronic myeloid leukemia (CML) drug repertoire

  • Yonglan Liu
  • , Mingzhen Zhang
  • , Hyunbum Jang
  • , Ruth Nussinov*
    • *Corresponding author for this work
  • National Institutes of Health
  • Leidos Inc

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Higher-order interactions of Bcr-Abl can broaden chronic myeloid leukemia (CML) drug repertoire'. Together they form a unique fingerprint.
Sort by

Keyphrases

Biochemistry, Genetics and Molecular Biology